Re: What population would our CD drug cover,...?
|
4
|
Resverlogix Corp.
|
Nov 27, 2019 11:20AM
|
What population would our CD drug cover,...?
|
3
|
Resverlogix Corp.
|
Nov 27, 2019 08:01AM
|
Re: Warrants conversion!
|
5
|
Resverlogix Corp.
|
Nov 26, 2019 06:34PM
|
Re: eGFR data question from IR
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 04:57PM
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 10:13AM
|
Re: Warrant Exercise Incentive Program
|
2
|
Resverlogix Corp.
|
Nov 26, 2019 06:37AM
|
Re: At 1.45 that's a 9% gain....
|
4
|
Resverlogix Corp.
|
Nov 26, 2019 06:36AM
|
eGFR data question from IR
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 12:30AM
|
Re: Useful review on epigenetics and CKD for the scientists
|
1
|
Resverlogix Corp.
|
Nov 25, 2019 10:35AM
|
Re: What value will be given Apabetalone for CD,...
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 09:50AM
|
Re: Useful review on epigenetics and CKD for the scientists
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 09:38AM
|
Re: A fair and optimistic write up on BETonMACE
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 08:52AM
|
Re: What value will be given Apabetalone for CD,...
|
1
|
Resverlogix Corp.
|
Nov 24, 2019 10:20PM
|
Re: What value will be given Apabetalone for CD,...
|
1
|
Resverlogix Corp.
|
Nov 24, 2019 09:01PM
|
What value will be given Apabetalone for CD,...
|
3
|
Resverlogix Corp.
|
Nov 24, 2019 07:43PM
|
Re: Biogen vs. Resverlogix, CTAD December 5
|
1
|
Resverlogix Corp.
|
Nov 23, 2019 10:41PM
|
Re: eGFR and Cognition?
|
2
|
Resverlogix Corp.
|
Nov 23, 2019 07:11PM
|
Re: eGFR and Cognition?
|
3
|
Resverlogix Corp.
|
Nov 23, 2019 09:06AM
|
Re: eGFR and Cognition?
|
1
|
Resverlogix Corp.
|
Nov 22, 2019 10:29PM
|
Re: eGFR and Cognition?
|
2
|
Resverlogix Corp.
|
Nov 22, 2019 05:10PM
|